Literature DB >> 11536201

Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications.

E Redenti1, L Szente, J Szejtli.   

Abstract

The objective of this mini-review is to summarize the findings concerning the physicochemical properties and the pharmaceutical applications of acidic drugs whose performances have been modified by simultaneous complexation with cyclodextrins and salt formation. Particular attention is paid to the approaches undertaken for increasing the solubility of the drugs by proper choice of the type of counterion analogously to what has been reported for complexes of basic drugs in the presence of hydroxy acids. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11536201     DOI： 10.1002/jps.1050

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


  9 in total

1.  Carvedilol: solubilization and cyclodextrin complexation: a technical note.

Authors:  Thorsteinn Loftsson; Stine Byskov Vogensen; Cyrielle Desbos; Phatsawee Jansook
Journal:  AAPS PharmSciTech       Date:  2008-03-05       Impact factor: 3.246

2.  Investigation of noncovalent complexes between beta-cyclodextrin and polyamide acids containing N-methylpyrrole and N-methylimidazole by electrospray ionization mass spectrometry.

Authors:  Huihui Li; Jiang Zhou; Feili Tang; Gu Yuan
Journal:  J Am Soc Mass Spectrom       Date:  2005-12-09       Impact factor: 3.109

3.  Interaction between cyclodextrin and neuronal membrane results in modulation of GABA(A) receptor conformational transitions.

Authors:  Maria Pytel; Katarzyna Mercik; Jerzy W Mozrzymas
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

4.  Cyclodextrins sequester neuroactive steroids and differentiate mechanisms that rate limit steroid actions.

Authors:  H-J Shu; C-M Zeng; C Wang; D F Covey; C F Zorumski; S Mennerick
Journal:  Br J Pharmacol       Date:  2006-12-11       Impact factor: 8.739

5.  Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.

Authors:  Abdul Ahad; Yousef A Bin Jardan; Mohd Zaheen Hassan; Mohammad Raish; Ajaz Ahmad; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

6.  Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.

Authors:  Ibrahim A Alsarra; Mahrous O Ahmed; Fars K Alanazi; Kamal Eldin Hussein Eltahir; Abdulmalik M Alsheikh; Steven H Neau
Journal:  Int J Med Sci       Date:  2010-07-05       Impact factor: 3.738

7.  Physicochemical characterization and cytotoxic activity evaluation of hydroxymethylferrocene:β-cyclodextrin inclusion complex.

Authors:  Rosa Iacovino; Jolanda Valentina Caso; Filomena Rapuano; Agostino Russo; Marina Isidori; Margherita Lavorgna; Gaetano Malgieri; Carla Isernia
Journal:  Molecules       Date:  2012-05-21       Impact factor: 4.411

8.  ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.

Authors:  Adamo Fini; Francesca Ospitali; Giorgio Zoppetti; Nadia Puppini
Journal:  Pharm Res       Date:  2008-07-03       Impact factor: 4.580

9.  Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies.

Authors:  Avez Sharipov; Zufar Boboev; Sunnatullo Fazliev; Shokhid Gulyamov; Akhmatkhodja Yunuskhodjayev; Jamoliddin Razzokov
Journal:  Pharmaceutics       Date:  2021-06-25       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.